Raymond James & Associates’s Integral Ad Science IAS Stock Holding History

Raymond James & Associates’s Portfolio IAS Stock Details IAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$886K	Buy	81,924 +24,613	+43%	+$265K	﹤0.01%	2768
2024 Q2	$557K	Sell	57,311 -2,111	-4%	-$20.2K	﹤0.01%	3010
2024 Q1	$592K	Buy	59,422 +18,887	+47%	+$252K	﹤0.01%	2960
2023 Q4	$583K	Sell	40,535 -3,278	-7%	-$43.9K	﹤0.01%	2854
2023 Q3	$521K	Sell	43,813 -45,576	-51%	-$705K	﹤0.01%	2864
2023 Q2	$1.61M	Buy	+89,389	New	+$1.51M	﹤0.01%	2193

Other funds holding IAS

VEPM

Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Raymond James & Associates's IAS Position: Q3 2024 in Review

Raymond James & Associates increased its Integral Ad Science (IAS) stake by 43% in Q3 2024, buying an estimated $265K and bringing the position to 81,924 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

Raymond James & Associates first reported a position in IAS in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.61M in Q2 2023. 172 funds tracked by Wall St. Rank hold IAS as of Q3 2024.

Raymond James & Associates held 81,924 shares of Integral Ad Science worth $886K as of Q3 2024.
Raymond James & Associates bought 24,613 Integral Ad Science shares in Q3 2024, an estimated $265K.
Integral Ad Science made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2768 holding.
Raymond James & Associates first reported a position in Integral Ad Science in Q2 2023 and has held it in 6 quarters since.
Raymond James & Associates's Integral Ad Science position peaked at $1.61M in Q2 2023.
172 funds tracked by Wall St. Rank held Integral Ad Science as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.